
    
      The study is aimed to evaluate the efficacy and safety of ENB guided RFA for the treatment of
      patients with early-stage non-small cell lung cancer (NSCLC). The study is designed as a
      single-center prospective trial with one arm. The participating centers are Department of
      pulmonary medicine and endoscopy, Shanghai Chest Hospital affiliated to Shanghai Jiao Tong
      University, China. Patients diagnosed with early-stage NSCLC will be enrolled into the study.
      Fifty patients are expected to be enrolled totally.
    
  